If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Directorate Change

22 Dec 2015 07:00

RNS Number : 7989J
Phorm Corporation Limited
22 December 2015
 

22 December 2015

 

Phorm Corporation Limited

("Phorm" or the "Company")

Directorate Change

Phorm (AIM: PHRM), a leading advertising-technology company and first party data platform provider, is pleased to announce the appointment of Mr Lin Jieyuan as a Non-Executive Director of the Company, with immediate effect.

Mr Jieyuan is currently the Chief Executive Officer of Pikai Pte. Ltd., a Singapore based company that specialises in providing outsourced accounting services to small and medium sized enterprises. Prior to this, from 2008 to 2011, he was Senior Accountant at Singapore based container terminals operator, PSA Corporation Limited. From 2005 to 2008, Mr Jieyuan worked as a Senior Associate at KPMG NV. He graduated from the Nanyang Technological University in Singapore with a B.A. in Accounting and is a member of the Institute of Singapore Chartered Accountants.

 

Additional information on Mr Lin Jieyuan

The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies:

 

Lin Jieyuan (aged 34)

 

Current Directorships/Partnerships

Past Directorships/Partnerships (last 5 years)

 

 

Apiag Holdings Pte. Ltd.

Financial Wealth Pte. Ltd.

Aseana Business Brokers Pte. Ltd.

Gelato Village Pte. Ltd.

Big Sync Music Pte. Ltd.

GS Energy Trading Singapore Pte. Ltd.

Boulder Investments Pte. Ltd.

Kodak Alaris Singapore Pte. Ltd.

BRG Consulting (Singapore) Pte Limited

Prosto Pte. Ltd.

Deguest Pte. Ltd.

Triton Orbital Pte. Ltd.

DSD Oilfield Pte. Ltd.

Venture Human Capital Pte. Ltd.

EV Management Ltd. (Singapore Branch)

OPT Sea Pte. Ltd.

Everstep Trading Pte. Ltd.

 

Firefish Insight Pte. Ltd.

 

Gogo SG Pte. Ltd.

 

Garolt Consulting Pte. Ltd.

 

Happy Healthy Futures Pte. Ltd.

 

Hillrose Hotels Pte. Ltd.

 

Inspiration Brands Pte. Ltd.

 

JDD (Singapore) Co. Pte. Ltd.

 

Jinbu Pte. Ltd.

 

Knauf Insulation Pte. Ltd.

 

LNC Investment Pte. Ltd.

 

Mblox Asia Pacific Pte. Ltd.

 

M2 Academy Pte. Ltd.

 

M2 Education (Singapore) Pte. Ltd.

 

M2 Venture Pte. Ltd.

 

More Than One Degree Pte. Ltd.

 

Natural Source Group Pte. Ltd.

 

Naturex Holdings Singapore Pte Limited

 

Ocean-Truck Logistics Group Co. Pte. Ltd.

 

OFE Trading Singapore Pte. Ltd.

 

Oriental Diamond Pte. Ltd.

 

Picchio Eyewear Pte. Ltd.

 

Pikai Pte. Ltd.

 

Reliv Singapore Pte. Ltd.

 

Sage Parts Pte. Ltd.

 

Seascape Ships Service Pte. Ltd.

 

Seer LLP

 

Services Development Co. Pte. Ltd.

 

Tanda Asia Trading Pte. Ltd.

 

Univera Singapore Pte. Ltd.

 

Very Italian Pizza Pte. Ltd.

 

Videology Media Technologies Pte. Ltd.

 

Wings4u Asia Pacific Pte. Ltd.

 

Yem Pte. Ltd.

 

Zuffa Singapore Pte. Ltd.

 

 

As disclosed above, Mr Jieyuan is a director of More Than One Degree Pte. Ltd, which entered into a creditors' voluntary liquidation on 19 October 2015, with an estimated total deficit as regards creditors of S$61,386.

 

He is also a director of M2 Venture Pte. Ltd, which entered into a creditors' voluntary liquidation on 19 October 2015, with an estimated total deficit as to creditors of S$20,185.

 

He is also a director of M2 Academy Pte. Ltd, which entered into a creditors' voluntary liquidation on 19 October 2015, with an estimated total deficit as to creditors of S$12,001,571.

 

In addition, Mr Jieyuan is a director of M2 Education (Singapore) Pte. Ltd, which entered into a creditors' voluntary liquidation on 4 November 2015, with an estimated total deficit as regards creditors of S$320,114.

 

There is no other information that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies.

 

 

-Ends-

For further information please contact: Phorm Corporation Limited

Timothy Smith (Chief Executive Officer) +44 (0) 20 3397 6001

 

Mirabaud Securities LLP (Broker) +44 (0) 20 7321 2508

Jason Woollard Peter Krens

 

Strand Hanson Limited (Nominated Adviser) +44 (0) 20 7409 3494

James Harris Matthew Chandler James Dance

 

About Phorm:

Phorm is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOADFLFLELFBFBE
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.